| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/10/2008 | WO2008080969A1 Carboxamide compounds and their use as calpain inhibitors |
| 07/10/2008 | WO2008080968A1 Freeze-dried injectable pharmaceutical combination of semisynthetic vinca alkaloids and carbohydrate stable at room temperature |
| 07/10/2008 | WO2008080965A2 Hiv inhibiting 5,6-substituted pyrimidines |
| 07/10/2008 | WO2008080964A1 Hiv inhibiting 6-substituted pyrimidines |
| 07/10/2008 | WO2008080956A1 Prognostic molecular markers for the cancer therapy with aplidine |
| 07/10/2008 | WO2008080955A1 Isosorbide mononitrate derivatives for the treatment of intestinal disorders |
| 07/10/2008 | WO2008080939A1 Isosorbide mononitrate derivatives for the treatment of ocular hypertension |
| 07/10/2008 | WO2008080938A1 Use 2-substituted pyridines for cancer treatment |
| 07/10/2008 | WO2008080937A1 2-substituted pyrimidines i in therapy |
| 07/10/2008 | WO2008080934A1 Stable s-nitrosothiols, method of synthesis and use |
| 07/10/2008 | WO2008080924A1 Use of 10-[(3r)-1-azabicyclo[2.2.2]oct-3-ylmethyl]-10h-phenothiazine for the preparation of a drug having a selective inhibition of muscarinic m1, m2 and m3 receptors |
| 07/10/2008 | WO2008080844A1 Azaspiro derivatives |
| 07/10/2008 | WO2008080842A1 Indoles |
| 07/10/2008 | WO2008080821A1 Crystalline forms glyt1 |
| 07/10/2008 | WO2008080810A2 Composition comprising cocoa fibre |
| 07/10/2008 | WO2008080773A1 Method for producing solid dosage forms containing graft copolymers |
| 07/10/2008 | WO2008080601A2 Process for the preparation of loperamide |
| 07/10/2008 | WO2008080542A2 Combination product for controlling parasites on animals |
| 07/10/2008 | WO2008080541A1 Agents for controlling parasites on animals |
| 07/10/2008 | WO2008080511A1 Heteroarylcyclopropanecarboxamides and their use as pharmaceuticals |
| 07/10/2008 | WO2008080461A1 5-phenyl-6-pyridin-4-yl-1,3-dihydro-2h-imidazo[4,5-b]pyridin-2-one derivatives useful as a2b adenosine receptor antagonists |
| 07/10/2008 | WO2008080455A1 Tetrahydrobenzoisoxazole - and tetrahydroindazole derivatives as modulators of the mitotic motor protein |
| 07/10/2008 | WO2008080413A2 An antisense oligonucleotide, pharmaceutical composition and a method for downregulation of peripheral neuronal nitric oxide synthase and mu-opioid receptors and use of an antisense oligonucleotide for drug production |
| 07/10/2008 | WO2008080408A1 Thioxanthene derivates usefulto treat infectious diseases |
| 07/10/2008 | WO2008080398A1 Anti - infective agents such as phenothiazine and thioxanthene derivates to treat infectious diseases |
| 07/10/2008 | WO2008080369A1 Steady liposomal composition |
| 07/10/2008 | WO2008080367A1 Liposome formulation and process for preparation thereof |
| 07/10/2008 | WO2008080336A1 Use of high osmotic liquid composition in manufacturing medicament for enhancing wound healing |
| 07/10/2008 | WO2008080333A1 Compound preparation for enhancing memory |
| 07/10/2008 | WO2008080291A1 Poly(glutamic acid)-drug conjugate with an amino acid as a linker |
| 07/10/2008 | WO2008080290A1 Selective m4 receptor antagonist and its medical use |
| 07/10/2008 | WO2008080287A1 L-carnitine calcium fumarate, preparation method and application for the same |
| 07/10/2008 | WO2008080268A1 Derivates of substituted tartaric aicd and usage for preparating beta secretase inhibitors |
| 07/10/2008 | WO2008080223A1 Compositions and methods for treating hyperproliferative disease |
| 07/10/2008 | WO2008080194A1 Pain-relieving compositions and uses therefor |
| 07/10/2008 | WO2008064311A3 Metallo-oxidoreductase inhibitors using metal binding moieties in combination with targeting moieties |
| 07/10/2008 | WO2008064136A3 Compounds with activity at retinoic acid receptors |
| 07/10/2008 | WO2008064107A3 7,8-dihydro-1,6-naphthyridin-5(6h)-ones and related bicyclic compounds as inhibitors of dipeptidyl peptidase iv and methods |
| 07/10/2008 | WO2008064107A2 7,8-dihydro-1,6-naphthyridin-5(6h)-ones and related bicyclic compounds as inhibitors of dipeptidyl peptidase iv and methods |
| 07/10/2008 | WO2008064039A3 Prostaglandin prodrugs as ocular hypotensive agents |
| 07/10/2008 | WO2008063600A3 Triazolyl tropane derivatives |
| 07/10/2008 | WO2008063284A3 Novel crystal of (s)-(+)-2-(2-chlorophenyl)-2-hydroxy-ethyl carbamate |
| 07/10/2008 | WO2008062206A3 Nucleoside aryl phosphoramidates and their use as anti-viral agents for the treatment of hepatitis c virus |
| 07/10/2008 | WO2008061966A3 New use of flibanserin |
| 07/10/2008 | WO2008061873A3 Stable powder formulation containing a novel anticholinergic agent |
| 07/10/2008 | WO2008061795A3 N- (methyl) -1h- pyrazol- 3 -amine, n- (methyl) -pyridin-2-amine and n- (methyl) -thiaz0l-2-amine derivatives for the treatment of diseases associated with amyloid or amyloid-like proteins, like e.g. alzheimer's |
| 07/10/2008 | WO2008061247A3 Benzenesulfonanilide compound inhibitors of urea transporters |
| 07/10/2008 | WO2008061108A3 Phthalazine derivatives |
| 07/10/2008 | WO2008060963A3 Layered pharmaceutical formulations comprising an intermediate rapidly dissolving layer |
| 07/10/2008 | WO2008060734A3 Nanoparticle compositions |
| 07/10/2008 | WO2008060332A9 Methods for treating or reducing muscle fatigue |
| 07/10/2008 | WO2008058867A3 Substituted 4-imidazoles |
| 07/10/2008 | WO2008058278A3 POLYMORPHS OF N2-(1, 1' - BIPHENYL - 4 - YLCARBONYL) - N1- [2- (4 - FLUOROPHENYL) -1, 1 - DIMETHYLETHYL]- L - α -GLUTAMINE |
| 07/10/2008 | WO2008058118A3 Preparation of montelukast and its salts |
| 07/10/2008 | WO2008057283A9 Use of resolvins for inhibition of bone loss |
| 07/10/2008 | WO2008056375A3 Pharmaceutical formulations comprising valsartan |
| 07/10/2008 | WO2008056266A3 Substituted 8-piperidinyl-2-pyridinyl-pyrimido [1,2-a]pyrimidin-6-one and 8-piperidinyl-2-pyrimidinyl-pyrimido[1,2-a]pyrimidin-6-one derivatives |
| 07/10/2008 | WO2008053393A3 Rotary actuator |
| 07/10/2008 | WO2008052798A3 Fgfr4 promotes cancer cell resistance in response to chemotherapeutic drugs |
| 07/10/2008 | WO2008052072A9 Compounds for the treatment of pain and screening methods therefor |
| 07/10/2008 | WO2008051902A3 Method of restoring the incretin effect |
| 07/10/2008 | WO2008051805A3 Triazolo-pyridazine protein kinase modulators |
| 07/10/2008 | WO2008051489A3 Salt forms of substituted benzothienyl compounds |
| 07/10/2008 | WO2008051404A3 Substituted imidazoles as bombesin receptor subtype-3 modulators |
| 07/10/2008 | WO2008051403A3 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
| 07/10/2008 | WO2008048991A3 Organic compounds |
| 07/10/2008 | WO2008046576B1 Use of glucocorticoid antagonists in vaccination |
| 07/10/2008 | WO2008043000A3 Ehrlicia canis diva (differentiate infected from vaccinated animals) |
| 07/10/2008 | WO2008040774A3 Angiotensin ii receptor antagonist for the treatment of systemic diseases in cats |
| 07/10/2008 | WO2008039431B1 Crystalline forms of 3-[5-(2-fhjorophenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid |
| 07/10/2008 | WO2008037037A3 Anti-asthmatic medicine comprising i. a. caffeine, ergotamine, zinc, papaverine, atropine, aminophyyline, glaucine etc. |
| 07/10/2008 | WO2008036932A3 Compositions and methods comprising boswellia species |
| 07/10/2008 | WO2008036652A3 Amidines as modulators of indoleamine 2,3-dioxygenase |
| 07/10/2008 | WO2008034008A3 Kinase inhibitors useful for the treatment of proliferative diseases |
| 07/10/2008 | WO2008031113A3 Improved method for inhibition of neovascularization |
| 07/10/2008 | WO2008029351A3 A modified release formulation comprising amoxicillin and clavulanate |
| 07/10/2008 | WO2008029294A3 Method of producing anthracycline derivatives |
| 07/10/2008 | WO2008024301A3 Bis(thiohydrazide amides) for use in preventing or delaying the recurrence of melanoma |
| 07/10/2008 | WO2008022046B1 Dicer substrate rna peptide conjugates and methods for rna therapeutics |
| 07/10/2008 | WO2008021975A3 Therapeutic lactams |
| 07/10/2008 | WO2008021796A3 Pyrrolidinone anilines as progesterone receptor modulators |
| 07/10/2008 | WO2008021368A3 Compositions and methods for neuroprotection |
| 07/10/2008 | WO2008021038A3 Pyridobenzazepine compounds and methods for inhibiting mitotic progression |
| 07/10/2008 | WO2008017278A3 Crystalline tolterodine tartarate and a pharmaceutical composition containing the same |
| 07/10/2008 | WO2008015558A3 Beta-3 receptor ligands and their use in therapy |
| 07/10/2008 | WO2008011700A8 Compositions and Methods for Alleviating Joint Pain and Improving Joint Flexibility |
| 07/10/2008 | WO2008011621A3 Protein kinase c zeta inhibition to treat vascular permeability |
| 07/10/2008 | WO2008011603A3 Modulating notch1 signaling pathway for treating neuroendocrine tumors |
| 07/10/2008 | WO2008010921A3 Modulators of pharmacokinetic properties of therapeutics |
| 07/10/2008 | WO2008008884A3 Inhibition of beta-amyloid peptide aggregation |
| 07/10/2008 | WO2008005742A3 Ibuprofen-containing liquid filled hard capsules |
| 07/10/2008 | WO2008005267A3 Sugar-free storage-stable antihistaminic syrups |
| 07/10/2008 | WO2008005084A3 Methods to prevent and treat diseases |
| 07/10/2008 | WO2008003093A3 Pharmaceutical compositions and related methods of treatment |
| 07/10/2008 | WO2008002929A3 Heterologous cross-sensitization for improved agonist activity |
| 07/10/2008 | WO2007150011A8 Prolyl hydroxylase inhibitors |
| 07/10/2008 | WO2007149366B1 Prolonged improvement of renal function comprising infrequent administration of an aa1ra |
| 07/10/2008 | WO2007143315A3 Compounds and methods for modulating expression of pcsk9 |
| 07/10/2008 | WO2007138047A3 Tri and tetra-oligo-saccharides suitable as agglutination agents for enteric pathogens |
| 07/10/2008 | WO2007131238A3 Compounds and methods for modulating expression apob |